Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati… - Bmj, 2015 - bmj.com
Protocols of systematic reviews and meta-analyses allow for planning and documentation of
review methods, act as a guard against arbitrary decision making during review conduct …
review methods, act as a guard against arbitrary decision making during review conduct …
Industry sponsorship and research outcome
Background Clinical research affecting how doctors practice medicine is increasingly
sponsored by companies that make drugs and medical devices. Previous systematic …
sponsored by companies that make drugs and medical devices. Previous systematic …
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
High quality protocols facilitate proper conduct, reporting, and external review of clinical
trials. However, the completeness of trial protocols is often inadequate. To help improve the …
trials. However, the completeness of trial protocols is often inadequate. To help improve the …
Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study
Background Systematic reviews (SRs) can help decision makers interpret the deluge of
published biomedical literature. However, a SR may be of limited use if the methods used to …
published biomedical literature. However, a SR may be of limited use if the methods used to …
Increasing value and reducing waste: addressing inaccessible research
The methods and results of health research are documented in study protocols, full study
reports (detailing all analyses), journal reports, and participant-level datasets. However …
reports (detailing all analyses), journal reports, and participant-level datasets. However …
[HTML][HTML] Dealing with the positive publication bias: Why you should really publish your negative results
A Mlinarić, M Horvat, V Šupak Smolčić - Biochemia medica, 2017 - hrcak.srce.hr
Sažetak Studies with positive results are greatly more represented in literature than studies
with negative results, producing so-called publication bias. This review aims to discuss …
with negative results, producing so-called publication bias. This review aims to discuss …
Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: A review
AP value, or the magnitude or direction of results can influence decisions about whether,
when, and how research findings are disseminated. Regardless of whether an entire study …
when, and how research findings are disseminated. Regardless of whether an entire study …
Failure of investigational drugs in late-stage clinical development and publication of trial results
TJ Hwang, D Carpenter, JC Lauffenburger… - JAMA internal …, 2016 - jamanetwork.com
Importance Many investigational drugs fail in late-stage clinical development. A better
understanding of why investigational drugs fail can inform clinical practice, regulatory …
understanding of why investigational drugs fail can inform clinical practice, regulatory …
Why clinical trial outcomes fail to translate into benefits for patients
C Heneghan, B Goldacre, KR Mahtani - Trials, 2017 - Springer
Clinical research should ultimately improve patient care. For this to be possible, trials must
evaluate outcomes that genuinely reflect real-world settings and concerns. However, many …
evaluate outcomes that genuinely reflect real-world settings and concerns. However, many …
COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time
B Goldacre, H Drysdale, A Dale, I Milosevic, E Slade… - Trials, 2019 - Springer
Background Discrepancies between pre-specified and reported outcomes are an important
source of bias in trials. Despite legislation, guidelines and public commitments on correct …
source of bias in trials. Despite legislation, guidelines and public commitments on correct …